Development of a Clinical Decision Support System for Cataract Surgery Planning Using Swept Source Optical Biometry (CAT-OCT)

November 9, 2026 updated by: Clínica de Oftalmología de Cali S.A

This single-center, observational, analytical, ambispective study aims to develop and internally validate a clinical decision support system for cataract surgery planning using swept-source optical coherence tomography (SS-OCT) integrated into the ARGOS optical biometer.

The study will evaluate the ability of preoperative crystalline lens tomographic patterns (Types I-III) to predict surgical complexity and the surgical approach required during cataract extraction. Additionally, it will assess whether SS-OCT-derived information provides incremental predictive value beyond conventional clinical assessment using the Lens Opacities Classification System III (LOCS III).

Clinical, biometric, and surgical data will be analyzed to determine the predictive performance, reproducibility, and technical feasibility of the proposed classification system. The ultimate goal is to establish an objective, noninvasive, and reproducible tool to support personalized surgical planning and preoperative risk stratification in cataract surgery.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Background and Rationale

Cataract remains a leading cause of visual impairment and preventable blindness worldwide. Although advances in surgical techniques and technology have improved cataract surgery outcomes, predicting surgical complexity and selecting the most appropriate surgical approach remain important clinical challenges. Currently, preoperative assessment relies primarily on clinical examination and subjective grading systems, such as the Lens Opacities Classification System III (LOCS III), which may exhibit interobserver variability.

Swept-source optical coherence tomography (SS-OCT), integrated into optical biometers such as ARGOS (Alcon Laboratories, Inc.), provides noninvasive, high-resolution images of the crystalline lens and biometric measurements. These images may reveal morphological characteristics associated with lens opacity, nuclear density, and surgical complexity.

This study proposes the development and internal validation of a clinical decision support system based on the identification of specific crystalline lens tomographic patterns to improve preoperative risk stratification and support cataract surgery planning.

Study Design and Population

This is a single-center, observational, analytical, ambispective study conducted at Clínica de Oftalmología de Cali, Colombia. The study will include patients older than 40 years undergoing crystalline lens extraction who have undergone preoperative optical biometry using the ARGOS device, including SS-OCT imaging of the crystalline lens.

The ambispective design will incorporate retrospectively identified surgical cases and prospectively included patients. Surgical management will follow routine clinical practice, without experimental treatment assignment or modification of the surgical technique by the investigators.

Patients undergoing combined cataract surgery with glaucoma, corneal, or retinal procedures, those with a history of significant ocular trauma affecting anterior segment anatomy, and patients with ocular conditions preventing reliable tomographic image acquisition will be excluded.

A reference group of patients with clear crystalline lenses who underwent ARGOS biometry for indications other than cataract will be used exclusively to characterize the Type I tomographic pattern. These individuals will not be included in the statistical analysis.

Preoperative Assessment and Tomographic Classification

Preoperative evaluation will include demographic characteristics, visual acuity, LOCS III cataract grading, relevant ocular comorbidities, and biometric parameters obtained using ARGOS.

Crystalline lens SS-OCT images will be classified according to three predefined tomographic patterns (Types I, II, and III), based on lens reflectivity, intralenticular signal distribution, and the morphological characteristics of the anterior and posterior lens peaks.

Images will be independently assessed by trained observers blinded to the surgical technique and intraoperative outcomes. Disagreements will be resolved through consensus or third-observer adjudication. Interobserver and intraobserver reproducibility will be evaluated.

Study Outcomes

The primary outcome will be the need for a complex surgical approach during cataract extraction, defined using prespecified objective criteria derived from surgical records and, when available, surgical recordings.

Secondary outcomes will include the specific surgical technique performed, conversion from the initially planned approach, phacoemulsification energy parameters, intraoperative complications, and technical feasibility of SS-OCT image acquisition and interpretation.

Statistical Analysis and Internal Validation

The predictive performance of the proposed tomographic classification will be assessed using sensitivity, specificity, positive and negative predictive values, likelihood ratios, and overall classification accuracy, with 95% confidence intervals.

Multivariable logistic regression will be used to evaluate the association between SS-OCT patterns and surgical complexity. A conventional clinical prediction model based on LOCS III and prespecified clinical variables will be compared with an expanded model incorporating the SS-OCT tomographic classification.

Model discrimination will be evaluated using the area under the receiver operating characteristic curve (AUC-ROC), while calibration will be assessed by comparing predicted and observed outcomes. Internal validation will be performed using bootstrap resampling.

Expected Clinical Relevance

The study seeks to determine whether SS-OCT-derived crystalline lens patterns can provide clinically useful information beyond conventional cataract grading. If validated, this classification could support more objective preoperative assessment, improve identification of surgically complex cases, and facilitate individualized cataract surgery planning using information already available from routine optical biometry.

The proposed system is intended to complement, rather than replace, clinical judgment. Further external validation will be required before its implementation in routine clinical practice.

Study Type

Observational

Enrollment (Actual)

499

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Valle del Cauca Department
      • Cali, Valle del Cauca Department, Colombia, 760036
        • Clínica de Oftalmología de Cali

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

For the establishment of the reference group with clear crystalline lenses, patients who underwent optical biometry using the ARGOS device for indications other than cataract, such as myopia monitoring, will be included to characterize the Type I pattern. These patients were not included in the statistical analysis of the study.

The study population will consist of patients older than 40 years with an indication for crystalline lens extraction and preoperative biometry performed using ARGOS, including acquisition of SS-OCT images of the crystalline lens. Patients in whom both the preoperative tomographic pattern and the surgical outcome can be adequately determined will be eligible.

Description

Inclusion Criteria:

  • Patients older than 40 years undergoing crystalline lens extraction surgery.
  • Preoperative optical biometry performed using the ARGOS biometer, including swept-source optical coherence tomography (SS-OCT) imaging of the crystalline lens.
  • Availability of sufficient preoperative tomographic information and surgical records to determine both the lenticular tomographic pattern and the surgical outcome.

Exclusion Criteria:

  • Patients undergoing combined cataract surgery with glaucoma, corneal, or retinal procedures.
  • Patients with a history of ocular trauma capable of significantly altering anterior segment anatomy.
  • Patients with ocular conditions that prevent the acquisition of reliable tomographic images using swept-source optical coherence tomography (SS-OCT).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Cataract Surgery Patients

Patients older than 40 years undergoing cataract surgery with preoperative swept-source optical coherence tomography (SS-OCT) imaging obtained using the ARGOS biometer. Lenticular tomographic patterns will be classified and evaluated for their ability to predict surgical complexity and the surgical approach required.

Preoperative assessment of crystalline lens tomographic patterns using swept-source optical coherence tomography (SS-OCT) integrated into the ARGOS optical biometer. Images will be classified according to predefined lenticular patterns (Types I-III) to evaluate their predictive value for surgical complexity and surgical approach during cataract extraction.

Other Names:
  • ARGOS Biometer
  • ARGOS Swept-Source OCT
  • SS-OCT Optical Biometry

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Predictive Performance of SS-OCT Lenticular Patterns for Surgical Complexity in Cataract Surgery
Time Frame: 6 months

Assessment of the ability of preoperative crystalline lens tomographic patterns (Types I-III), obtained using swept-source optical coherence tomography (SS-OCT) with the ARGOS biometer, to predict the need for a complex surgical approach during cataract extraction. Surgical complexity will be classified as conventional or complex according to predefined objective criteria derived from operative records. Predictive performance will be evaluated using sensitivity, specificity, positive and negative predictive values, likelihood ratios, and overall classification accuracy, with 95% confidence intervals.

6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incremental Predictive Value of SS-OCT Compared With LOCS III
Time Frame: 6 months

Evaluation of the additional predictive value of SS-OCT lenticular patterns beyond conventional clinical assessment using LOCS III. Predictive models will be compared in terms of discrimination, measured by the area under the receiver operating characteristic curve (AUC-ROC), and calibration.

6 months
Distribution of Surgical Techniques Across SS-OCT Lenticular Pattern Categories
Time Frame: 6 months

To determine the percentage of eyes undergoing each surgical technique within the preoperative lenticular pattern categories (I, II, and III), as classified using swept-source optical coherence tomography (SS-OCT) images obtained with the ARGOS optical biometer.

Surgical techniques will be identified from operative records and categorized as phacoemulsification (divide and conquer, stop and chop, vertical chop, or horizontal chop), extracapsular cataract extraction, or manual small-incision cataract surgery (MSICS).

The frequency distribution of surgical techniques will be compared across SS-OCT lenticular pattern categories using appropriate categorical statistical methods.

6 months
Cumulative Dissipated Energy During Phacoemulsification Across SS-OCT Lenticular Pattern Categories
Time Frame: 6 months

To quantify cumulative dissipated energy (CDE) during cataract surgery performed using phacoemulsification and describe its distribution across preoperative SS-OCT lenticular pattern categories (I, II, and III).

CDE will be obtained from the phacoemulsification system records and expressed in the units reported by the device.

Differences in CDE across lenticular pattern categories will be evaluated using statistical methods appropriate to the observed distribution of the data.

6 months
Interobserver and Intraobserver Reproducibility of SS-OCT Lenticular Pattern Classification
Time Frame: 6 months

Assessment of interobserver and intraobserver agreement in the classification of SS-OCT lenticular patterns (Types I-III), using percentage agreement and Cohen's kappa coefficient with 95% confidence intervals.

6 months
Incidence of Intraoperative Complications
Time Frame: 6 months

Assessment of the occurrence of intraoperative complications during cataract surgery and their association with preoperative SS-OCT lenticular patterns. Complication frequencies will be reported according to tomographic pattern classification.

6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2026

Primary Completion (Actual)

October 19, 2026

Study Completion (Actual)

October 19, 2026

Study Registration Dates

First Submitted

October 20, 2026

First Submitted That Met QC Criteria

November 9, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 9, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2020001-01
  • 2020001-01 (Other Identifier: Self-financed)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Time Frame

In 6 months

IPD Sharing Access Criteria

Restricted access by request

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.